IVIg Immune Reconstitution Treatment Alleviates the State of Persistent Immune Activation and Suppressed CD4 T Cell Counts in CVID (2013)
- Authors:
- USP affiliated authors: KALLAS, ESPER GEORGES - FM ; KALIL FILHO, JORGE ELIAS - FM
- Unidade: FM
- DOI: 10.1371/journal.pone.0075199
- Subjects: DOENÇAS AUTOIMUNES; TÉCNICAS E PROCEDIMENTOS DE LABORATÓRIO; CITOMETRIA DE FLUXO; IMUNOLOGIA CELULAR
- Language: Inglês
- Imprenta:
- Publisher place: San Francisco
- Date published: 2013
- Source:
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
PAQUIN-PROULX, Dominic et al. IVIg Immune Reconstitution Treatment Alleviates the State of Persistent Immune Activation and Suppressed CD4 T Cell Counts in CVID. PLOS ONE, v. 8, n. 10, p. 9 , 2013Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0075199. Acesso em: 31 mar. 2026. -
APA
Paquin-Proulx, D., Santos, B. A. N., Carvalho, K. I., Toledo-Barros, M., Oliveira, A. K. B. de, Kokron, C. M., et al. (2013). IVIg Immune Reconstitution Treatment Alleviates the State of Persistent Immune Activation and Suppressed CD4 T Cell Counts in CVID. PLOS ONE, 8( 10), 9 . doi:10.1371/journal.pone.0075199 -
NLM
Paquin-Proulx D, Santos BAN, Carvalho KI, Toledo-Barros M, Oliveira AKB de, Kokron CM, Kalil J, Moll M, Kallas EG, Sandberg JK. IVIg Immune Reconstitution Treatment Alleviates the State of Persistent Immune Activation and Suppressed CD4 T Cell Counts in CVID [Internet]. PLOS ONE. 2013 ; 8( 10): 9 .[citado 2026 mar. 31 ] Available from: https://doi.org/10.1371/journal.pone.0075199 -
Vancouver
Paquin-Proulx D, Santos BAN, Carvalho KI, Toledo-Barros M, Oliveira AKB de, Kokron CM, Kalil J, Moll M, Kallas EG, Sandberg JK. IVIg Immune Reconstitution Treatment Alleviates the State of Persistent Immune Activation and Suppressed CD4 T Cell Counts in CVID [Internet]. PLOS ONE. 2013 ; 8( 10): 9 .[citado 2026 mar. 31 ] Available from: https://doi.org/10.1371/journal.pone.0075199 - CD4+ T-cell activation impairs serogroup C Neisseria meningitis vaccine response in HIV-infected children
- Invariant natural killer T cells in patients with common variable immunodeficiency [Carta]
- Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine
- Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial
- A pre-vaccination immune metabolic interplay determines the protective antibody response to a dengue virus vaccine
- Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection
- CD57 Expression and Cytokine Production by T Cells in Lesional and Unaffected Skin from Patients with Psoriasis
- The CD8+ Memory Stem T Cell (TSCM) Subset Is Associated with Improved Prognosis in Chronic HIV-1 Infection
- Short Communication: HIV Type 1 Subtype BF Leads to Faster CD4+ T Cell Loss Compared to Subtype B
- Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
